Claim Missing Document
Check
Articles

Found 3 Documents
Search

Raynaud’s Phenomenon in A Patient with Scleroderma: A Case Report Hutagalung, Patricia; Nababan, Kristo Alberto
Indonesian Journal of Global Health Research Vol 7 No 5 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i5.6631

Abstract

Systemic sclerosis, or scleroderma, is a chronic autoimmune disorder characterized by fibrosis of the skin and internal organs, vasculopathy, and immune dysregulation. Raynaud’s phenomenon (RP), marked by episodic vasospasm of the digital arteries in response to cold exposure or emotional stress, is often one of the earliest and most common sign of SSc. Early diagnosis plays a crucial role in preventing and managing complications of RP, such as digital ulcers and tissue damage due to chronic circulatory impairment, as well as in reducing long-term disability. This case report aims to highlight pedal ulcers as a complication of RP scleroderma and to emphasize the importance of early intervention in preventing progressive tissue damage. The data was conducted through a comprehensive approach including history assessment, physical examinations, electronic medical record reviews, laboratory diagnostics, and imaging studies to ensure accurate diagnosis and effective interventions. We report a 26-year-old woman who presented with a six-month history of progressive skin thickening and hardening involving almost all of her body. The patient also experienced finger stiffness, flexion contractures, and limited mouth opening. Dermatological examination revealed sclerotic skin with hypopigmented and hyperpigmented patches forming a "salt-and-pepper" appearance across various body areas, along with microstomia and a beaked nose. The Modified Rodnan Skin Score (mRSS) was 34. A diagnosis of systemic sclerosis was established based on the American College of Rheumatology in collaboration with the European League Against Rheumatism (ACR/EULAR) criteria. The patient was lost to follow-up after the initial visit and later returned with toe necrosis and ulceration over the ankle area. Treatment included systemic corticosteroids combined with methotrexate, along with counseling to avoid cold exposure and manage stress. Raynaud’s phenomenon should be recognized as a critical early sign of scleroderma. Comprehensive early evaluation, including autoantibody testing, is essential for timely diagnosis and the prevention of severe vascular complications.
Marked Clinical Improvement of Psoriasis Vulgaris with Methotrexate: A Case Report with 75% PASI Reduction Manurung, Widya Gabriella; Nababan, Kristo Alberto
Indonesian Journal of Global Health Research Vol 7 No 5 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i5.6859

Abstract

Psoriasis is an immune-mediated chronic, recurrent, systemic inflammatory disease induced by the combination of hereditary and environmental factors. The etiology of this disease involves many factors, including genetics, immunology, and the environment. Clinically, psoriasis vulgaris is characterized by the presence of reddish plaques with thick, symmetrically distributed squama mainly in the predilection areas. In moderate to severe cases, systemic therapy such as phototherapy, systemic anti-inflammatory agents, or biologic treatments is required, with topical therapy serving as an adjunct. Methotrexate is one of the effective systemic treatment options for severe psoriasis, either as monotherapy or in combination regimens. This case report aims to demonstrate the clinical efficacy of methotrexate in the management of moderate-to-severe psoriasis vulgaris. We report a case of a 37-year-old male presenting with scaly reddish skin thickening accompanied by itching all over the body. Clinical and histopathological examination confirmed the diagnosis of Psoriasis Vulgaris and treated with methotrexate. After a period of regular weekly methotrexate administration and monitoring, the patient achieved a 75% reduction in the Psoriasis Area and Severity Index (PASI), indicating significant therapeutic response. This case highlights the efficacy of methotrexate as a cost-effective and accessible treatment option for achieving substantial disease control in psoriasis vulgaris.
Nipple Dermatitis as a Localized Manifestation of Atopic Dermatitis: A Case Report Malinda, Ifen Ayu; Nababan, Kristo Alberto
Indonesian Journal of Global Health Research Vol 7 No 5 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i5.6909

Abstract

Nipple dermatitis is an inflammatory skin condition affecting the areolar and nipple region, most commonly associated with atopic dermatitis (AD). It presents significant diagnostic challenges due to its overlapping features with other conditions such as irritant contact dermatitis, allergic contact dermatitis, Paget’s disease, and cutaneous . This case report aims to present the diagnostic approach and management of nipple dermatitis in an adolescent patient, highlighting its clinical relevance and differential diagnosis.This case report discusses a 16-year-old female presenting with bilateral nipple dermatitis, initially suspected to have malignancy. Comprehensive evaluation including cytology, ultrasonography, and KOH examination ruled out malignancy and fungal infection. A working diagnosis of nipple dermatitis secondary to atopic dermatitis was established. The patient responded well to topical corticosteroids, emollients, antihistamines, and supportive care. This case highlights the importance of accurate clinical assessment and individualized treatment in managing nipple dermatitis, particularly in adolescents. Early identification and appropriate intervention can prevent chronicity and improve patient quality of life.